Luyckx A S, Mendoza E, Lefebvre P
Arch Int Pharmacodyn Ther. 1980 Dec;248(2):305-13.
Eight overnight fasted healthy young volunteers received an intravenous infusion of 0.5 mg furosemide per kg body weight administered in 60 min. This period was preceded and followed by two control periods of one hour each during which physiological saline (o.154 mol/l) was administered at a rate of 1 ml/min. Furosemide markedly increased the diuresis and natriuresis which reached 1260 +/- 198 ml and 138.4 +/- 20.9 mmol per hour respectively. This was associated with a significant three fold increase in urinary total catecholamines excretion. Blood glucose, plasma free fatty acids, insulin and glucagon concentrations did not exhibit any significant change during and after furosemide infusion, compared to pre-infusion values. These results demonstrate that, in normal man, doses of furosemide capable of exerting plasma concentrations. It is concluded that the stimulation of insulin and glucagon secretion observed in vitro with high furosemide concentrations (5 mmol/l) are not observed under usual therapeutic conditions.
八名健康的年轻志愿者在禁食过夜后,接受了按每千克体重0.5毫克呋塞米的剂量在60分钟内静脉输注。在此期间之前和之后各有两个1小时的对照期,期间以1毫升/分钟的速率输注生理盐水(0.154摩尔/升)。呋塞米显著增加了利尿和利钠作用,分别达到每小时1260±198毫升和138.4±20.9毫摩尔。这与尿中总儿茶酚胺排泄量显著增加三倍有关。与输注前的值相比,在呋塞米输注期间及之后,血糖、血浆游离脂肪酸、胰岛素和胰高血糖素浓度均未出现任何显著变化。这些结果表明,在正常人体内,呋塞米剂量能够产生血浆浓度。得出的结论是,在通常的治疗条件下,未观察到在体外高浓度呋塞米(5毫摩尔/升)时所观察到的胰岛素和胰高血糖素分泌刺激作用。